Hot New Products From The World Leader In Probiotic Technology


Last week, we discussed some of the key points for you to consider when selecting probiotics for maximum therapeutic effectiveness.

Today, we’ll look at two very hot specialty probiotic products that help fill out the selection of 21 formulas from Pharmax: An exciting top-drawer HLC Multi Strain, and another doctor favorite named HLC Antibiotic Care.

In addition to providing a vast selection of probiotics for therapeutic applications, Pharmax also provides an array of really exciting specialty probiotic formulas.

In the last blog post, we discussed the importance of using proven human strains that can be identified by a strain number and human studies that assures us of certain key properties. Human strains that are acid- and bile-resistant and have strong bowel-adherence properties are always preferred for effective therapy.

Pharmax’s new HLC Multi Strain Formula has 13 identified and proven proprietary human strains, and an additional 3 proven human strains for a total of 16 strains. Would you rather have 16 proven human resilient strains, or 25 unproven and unidentified non-human strains? This HLC Multi Strain Formula is recommended for moderate daily maintenance needs.

Our NEW HLC Antibiotic Care is clinically proven to supplement intestinal microbiota following antibiotic therapy. The serving size is 14 capsules, providing 200 billion CFU per dose with refrigeration and 100 billion without refrigeration.

The Federal Canadian health department, Health Canada, has approved HLC Antibiotic Care for the “effective supplementation of normal intestinal microbiota following antibiotic therapy.”

Anova Health recommends HLC Antibiotic Care during and immediately following antibiotic use to repopulate intestinal flora with clinically proven human strains.

Pharmax’s meticulously selected, human-derived probiotic strains more easily survive the rigors of the intestinal environment, and are more efficient at colonizing the intestinal lining, ultimately yielding greater benefits. The Cambridge Probiotic/Antibiotic Clinical Trial—a double-blind, placebo-controlled clinical trial that was published in the International Journal of Antimicrobial Agents—revealed that Pharmax’s proprietary HLC blend offers proven post-antibiotic replenishment and care by promoting a healthy microflora. This is yet another example of Pharmax’s ongoing commitment to incorporate safe and effective formulas that reflect the latest evidence-based research.

Speak Your Mind